KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Free Cash Flow (2017 - 2025)

Historic Free Cash Flow for Twist Bioscience (TWST) over the last 9 years, with Q4 2025 value amounting to -$34.8 million.

  • Twist Bioscience's Free Cash Flow fell 4680.96% to -$34.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$86.7 million, marking a year-over-year decrease of 2681.36%. This contributed to the annual value of -$75.6 million for FY2025, which is 934.22% down from last year.
  • As of Q4 2025, Twist Bioscience's Free Cash Flow stood at -$34.8 million, which was down 4680.96% from -$24.2 million recorded in Q3 2025.
  • Twist Bioscience's Free Cash Flow's 5-year high stood at -$7.3 million during Q2 2024, with a 5-year trough of -$74.8 million in Q2 2022.
  • In the last 5 years, Twist Bioscience's Free Cash Flow had a median value of -$26.2 million in 2023 and averaged -$34.3 million.
  • As far as peak fluctuations go, Twist Bioscience's Free Cash Flow tumbled by 12552.35% in 2022, and later skyrocketed by 7370.08% in 2024.
  • Over the past 5 years, Twist Bioscience's Free Cash Flow (Quarter) stood at -$59.4 million in 2021, then decreased by 10.87% to -$65.9 million in 2022, then soared by 62.85% to -$24.5 million in 2023, then increased by 3.2% to -$23.7 million in 2024, then tumbled by 46.81% to -$34.8 million in 2025.
  • Its last three reported values are -$34.8 million in Q4 2025, -$24.2 million for Q3 2025, and -$10.6 million during Q2 2025.